BESAFE
Financiado
ARTIFICIAL INTELLIGENCE ENHANCEMENT OF SURGICAL TECHNOLOGY FOR THE REDUCTION OF...
ARTIFICIAL INTELLIGENCE ENHANCEMENT OF SURGICAL TECHNOLOGY FOR THE REDUCTION OF HUMAN BEHAVIOUR RELATED SURGICAL ACCIDENTS
BESAFE seeks to support the exploitation of the results from the IBSEN FET project and capture a market opportunity as well as address a poignant societal need, the reduction of intra-operative accidents and surgery costs by means...
BESAFE seeks to support the exploitation of the results from the IBSEN FET project and capture a market opportunity as well as address a poignant societal need, the reduction of intra-operative accidents and surgery costs by means of clinical decision support software.
IBSEN has led to the development of a general-purpose novel artificial intelligence tool based on unsupervised machine learning algorithms. The software learns from the behaviour of individuals and their outcomes. It can be adapted for automated early detection and correction of high-risk actions by members of surgical teams.
The coordinator of the BESAFE consortium, Afferent Technologies, has expertise in prevention of accidental surgical nerve-damage, a costly and dramatic event, by means of electrophysiological technology. The BESAFE software, endowed with artificial intelligence from the ISEB project, has the potential for a quantum leap in the market.
The key deliverables of BESAFE are a) the business plan, with detailed financials and market analysis, as well as an estimate of remaining technical milestones, as required to progress from the IBSEN deliverables to the final certifiable software, b) a demonstration of the use of the Artificial Intelligence IBSEN algorithms to recognise patterns of behaviour (high risk vs low risk) by analysis of machine-user interaction patterns.
The final aim of BESAFE is to produce a well-studied investable opportunity for Venture Capital coinciding with an increased interest of these stakeholders in the Artificial Intelligence and Medical Technology spaces.
ver más
Duración del proyecto: 12 meses
Fecha Inicio: 2019-04-16
Fecha Fin: 2020-04-30
Fecha Fin: 2020-04-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2020-04-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
FETOPEN-03-2018-2019-2020:
FET Innovation Launchpad
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
100K€
Líder del proyecto
AFFERENT TECHNOLOGIES
El desarrollo, fabricacion y comercializacion de instrumentos medicos. cnae actividad principal: 7219 (otra investigacion y desarrollo exper...
Perfil tecnológico
TRL
4-5
50K
Perfil tecnológico
TRL
4-5
50K